• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

PDA ‘seriously’ concerned with apparent failure of employers

4th August 2020 by PIP editor Leave a Comment

 

The Pharmacist Defence Association (PDA) has formally written to the General Pharmaceutical Council (GPhC) with their concerns about the failure of community pharmacy employers to report any instances of likely exposure to the coronavirus in the workplace.

 

The PDA has said that they are seriously concerned that there appears to be a ‘failure’ of Community Pharmacy employers to appropriately report instances of exposure to COVID in the workplace.

 

The PDA have previously highlighted these issues.

 

  • In April, the PDA welcomed the guidance issued by the Health and Safety Executive (HSE).
  • In May, the PDA raised concerns that it seemed some employers in community pharmacy were not meeting those reporting requirements.
  • In early July, the PDA highlighted that a parliamentary question had revealed despite reporting happening from employers in other parts of the health system, there had been zero reports from community pharmacy.
  • Later in July, the PDA reported results of a survey in which four in ten pharmacists who had caught the coronavirus believed they had been exposed in the workplace.

 

The PDA have said that in the absence of any change of approach by community pharmacy employers and with no indication of any action being taken by the regulator the PDA has now formally raised their concerns.

 

Commenting within the letter PDA Director Paul Day said:

 

“As with health professionals in other sectors, throughout the lockdown period Community Pharmacists, and their teams will have been following social distancing and government guidelines outside of work to minimise the risk of catching coronavirus and avoiding contact with others. Most interactions with people from outside their household will, therefore, have been while they were at work, spending time with colleagues and patients in what are often cramped pharmacy workspaces. Community pharmacy is a high contact environment, and this is not just our description as the largest community pharmacy employer recently announced that it was joining a pilot to evaluate the effectiveness of testing for people without symptoms of COVID-19 who work in “high-contact” jobs.

 

“Confidence in community pharmacy employers properly discharging their duties regarding the health and safety of patients and employees is fundamental. The responsibility lies clearly with employers and the absence of any notifications whatsoever for work acquired COVID infections in the community sector must cast significant doubt on compliance with these strict obligations.

 

“All five principles set out in the “Standards for Registered Pharmacies” identify safeguarding “the health, safety and wellbeing of patients and the public” as the objective; employers and the regulator have no hesitation in holding individuals to account for any failure to comply with legal and professional obligations. It is therefore incumbent on the GPhC to investigate further the unexplained and complete absence of work acquired COVID infection reporting by community pharmacy employers.”

 

“We would be grateful if you would confirm what action, if any, the GPhC will take with regard to this situation and I look forward to hearing from you. We have copied this letter to the CEOs of the main community pharmacy employer representative bodies.”

 

Have your say by telling us if you or your team have tested positive for COVID-19.

 

We'll use your email address only to get back in touch with you after filling in this form.
We welcome all contributions and personal opinions are encouraged but please do make sure you back up any claims with suitable references.

 

 

 

Related

Next article  GPhC say assessment is an 'essential step' towards registration

Filed Under: News Tagged With: PDA

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

PIP business directory

Letters to the editor

Letters to the editor

Pharmacists should follow Canada and be able to change prescriptions

Pharmacists are disillusioned, disenfranchised and marginalised

It is difficult to know how to ask a patient if they can read

Is a pharmacist who sells rapid antibody tests unfit to practise?

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.